Key facts
- It has raised $33.0M across 7 recorded rounds; the latest was Early Stage VC ($8.3M) in Dec 2025.
- Notable investors include HM Venture Partners, Southeast Minnesota Capital Fund.
- Minnesota Medical Technologies has filed 9 Form Ds with the SEC since 2018, most recently Dec 2025 ($8.3M sold to 18 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 7 rounds
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Minnesota Medical Technologies
Funding rounds
7 roundsAbout Minnesota Medical Technologies
Operator of a medical technology company intended to develop, make and sell fecal continence care products. The company offers products designed to prevent accidental leakage and not contain, absorb or cover it, enabling patients to manage their FI symptoms.
- Sector
- Healthcare
- HQ
- Stewartville, MN, United States
- Founded
- 2015
- Employees
- 15
- Website
- mnmedicaltechnologies.com/
- Ownership
- Privately Held (backing)
Minnesota Medical Technologies doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Minnesota Medical Technologies shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Minnesota Medical Technologies in its N-PORT filings yet. We sweep new filings monthly.